PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

NCT01521494 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease Requiring Hemodialysis

Interventions

DRUG: PA21
DRUG: PA21
DRUG: PA21
DRUG: PA21
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.